Lifeon Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 121 million yuan, a year-on-year increase of 1.65%

Zhitong
2025.10.29 08:49
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, Lifeon Pharmaceutical released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 1.081 billion yuan, a year-on-year decrease of 3.95%. The net profit attributable to shareholders of the listed company was 121 million yuan, a year-on-year increase of 1.65%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 89.3546 million yuan, a year-on-year decrease of 20.23%

According to the Zhitong Finance APP, Lifeon Pharmaceutical (003020.SZ) released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 1.081 billion yuan, a year-on-year decrease of 3.95%. The net profit attributable to shareholders of the listed company was 121 million yuan, a year-on-year increase of 1.65%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 89.3546 million yuan, a year-on-year decrease of 20.23%

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.